VX-661
- CAS No.
- 1152311-62-0
- Chemical Name:
- VX-661
- Synonyms
- tezacaftor(VX661);(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-Methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxaMide;CS-956;VX-661;VX-661/VX661;VX661/Tezacaftor;VX-661 USP/EP/BP;VX 661; VX661;VX-661;VX 661;VX661;VX-661; TEZACAFTOR;Tezacaftor D4Q: What is Tezacaftor D4 Q: What is the CAS Number of Tezacaftor D4
- CBNumber:
- CB22632076
- Molecular Formula:
- C26H27F3N2O6
- Molecular Weight:
- 520.5
- MDL Number:
- MFCD23106064
- MOL File:
- 1152311-62-0.mol
- MSDS File:
- SDS
Boiling point | 610.8±55.0 °C(Predicted) |
---|---|
Density | 1.49±0.1 g/cm3(Predicted) |
storage temp. | Store at -20°C , stored under nitrogen |
solubility | ≥21.8 mg/mL in DMSO; insoluble in EtOH; ≥24.3 mg/mL in H2O |
form | solid |
pka | 13.99±0.20(Predicted) |
FDA UNII | 8RW88Y506K |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302-H315-H319-H335 | |||||||||
Precautionary statements | P261-P305+P351+P338 | |||||||||
NFPA 704 |
|
VX-661 price More Price(27)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 21480 | VX-661 ≥98% | 1152311-62-0 | 5mg | $62 | 2024-03-01 | Buy |
Cayman Chemical | 21480 | VX-661 ≥98% | 1152311-62-0 | 10mg | $115 | 2024-03-01 | Buy |
Cayman Chemical | 21480 | VX-661 ≥98% | 1152311-62-0 | 25mg | $239 | 2024-03-01 | Buy |
Cayman Chemical | 21480 | VX-661 ≥98% | 1152311-62-0 | 50mg | $448 | 2024-03-01 | Buy |
TRC | T321510 | Tezacaftor | 1152311-62-0 | 1mg | $55 | 2021-12-16 | Buy |
VX-661 Chemical Properties,Uses,Production
Description
Tezacaftor (VX-661) is an oral medication for cystic fibrosis (CF) developed by Vertex Pharmaceuticals. In a combination therapy formulation called Symdeko (tezacaftor plus ivacaftor), it is approved in the U.S. and Canada for CF patients, ages 12 and older, who have two copies of the F508del mutation in the CFTR gene and one minimal function mutation. Symdeko is approved and marketed in the EU as Symkevi.Tezacaftor is not approved as a stand-alone treatment, but as part of a combination therapy.
Uses
Tezacaftor is used as a combination therapy with Ivacaftor for the treatment of patients with cystic fibrosis.
Definition
VX-661 is an investigational compound that promotes the maturation of delta F508 mutants of the cystic fibrosis transmembrane conductance regulator (CFTR). Delta F508 CFTR represents a class of CFTR mutation that is characterized by impaired processing of misfolded CFTR proteins and reduced accumulation of the protein at the cell surface. VX-661 is intended to facilitate trafficking of CFTR to the epithelial cell membrane. It may be combined with the CFTR potentiator ivacaftor (Item No. 15145) to stimulate both CFTR accumulation and opening at the apical epithelial surface.
Biochem/physiol Actions
VX-661 is another cystic fibrosis transmembrane conductance regulator (CFTR) corrector in development for the treatment of cystic fibrosis.
in vitro
VX-661, is CFTR modulator that is potentially useful for treatment of cystic fibrosis. VX-661 corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro.
target
F508 del CFTR
References
[1] s. donaldson, j. pilewski, m. griese, q. dong, p.-s. lee, for the vx11–661-101 study group. ws7.3 vx-661, an investigational cftr corrector, in combination with ivacaftor, a cftr potentiator, in patients with cf and homozygous for the f508del-cftr mutation: interim analysis. journal of cystic fibrosis, volume 12, supplement 1, june 2013, page s14
VX-661 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 | fandachem@gmail.com | China | 9354 | 55 |
career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29914 | 58 |
Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 967 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-61398051 +8613650506873 | sales@chemdad.com | China | 39916 | 58 |
ENBRIDGE PHARMTECH CO., LTD. | +8613812269233 | tinayang@enbridgepharm.com | China | 301 | 58 |
Zhengzhou Alfa Chemical Co.,Ltd | +8618530059196 | sale04@alfachem.cn | China | 12333 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
Allfluoro pharmaceutical co. ltd. | 021-26137118 +8615821363818 | sales@allfluoro.com | China | 5791 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6313 | 58 |
View Lastest Price from VX-661 manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
2021-11-15 | VX-661
1152311-62-0
|
US $0.20 / g | 1KG | 99% | 500ton/Month | Qiuxian Baitai New Material Co., LTD | ||
2021-10-08 | tezacaftor;VX661
1152311-62-0
|
US $0.00-0.00 / g | 1g | 98% | 1000kgs | Wuhan Nutra Biotechnology Co.,Ltd | ||
2019-07-06 | VX-661
1152311-62-0
|
US $8.00 / kg | 1kg | 99% | 100MT | Career Henan Chemical Co |
- VX-661
1152311-62-0
- US $0.20 / g
- 99%
- Qiuxian Baitai New Material Co., LTD
- tezacaftor;VX661
1152311-62-0
- US $0.00-0.00 / g
- 98%
- Wuhan Nutra Biotechnology Co.,Ltd
- VX-661
1152311-62-0
- US $8.00 / kg
- 99%
- Career Henan Chemical Co
1152311-62-0(VX-661)Related Search:
1of3